Literature DB >> 24509086

Considerations on manganese (Mn) treatments for in vitro studies.

Aaron B Bowman1, Michael Aschner2.   

Abstract

Manganese (Mn) is an environmental risk factor for neuronal dysfunction and neurodegeneration of the basal ganglia and other brain regions. Aberrant brain Mn levels have been linked to manganism, Parkinson's disease (PD), Huntington's disease (HD) and other neurological disorders. Research on the cellular basis of Mn neurotoxicity has relied upon in vitro or non-human model systems. However, an analysis of relevant Mn concentrations for in vitro studies is lacking - and few studies have examined intracellular Mn levels. Here we perform calculations to evaluate in vitro exposure paradigms in relation to relevant in vivo levels of Mn post-exposure.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain concentrations; In vitro; Manganese; Toxicity

Mesh:

Substances:

Year:  2014        PMID: 24509086      PMCID: PMC4004588          DOI: 10.1016/j.neuro.2014.01.010

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  15 in total

Review 1.  Effects from environmental Mn exposures: a review of the evidence from non-occupational exposure studies.

Authors:  H K Hudnell
Journal:  Neurotoxicology       Date:  1999 Apr-Jun       Impact factor: 4.294

2.  Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders.

Authors:  B A Racette; S D Tabbal; D Jennings; L Good; J S Perlmutter; B Evanoff
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

Review 3.  The diagnosis of manganese-induced parkinsonism.

Authors:  Maria G Cersosimo; William C Koller
Journal:  Neurotoxicology       Date:  2005-12-01       Impact factor: 4.294

4.  Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposure.

Authors:  B Blairanne Williams; Daphne Li; Michal Wegrzynowicz; Bhavin K Vadodaria; Joel G Anderson; Gunnar F Kwakye; Michael Aschner; Keith M Erikson; Aaron B Bowman
Journal:  J Neurochem       Date:  2009-10-21       Impact factor: 5.372

5.  Visualizing manganese in the primate basal ganglia with magnetic resonance imaging.

Authors:  M C Newland; T L Ceckler; J H Kordower; B Weiss
Journal:  Exp Neurol       Date:  1989-12       Impact factor: 5.330

Review 6.  Manganese and Parkinson's disease: a critical review and new findings.

Authors:  Tomás R Guilarte
Journal:  Environ Health Perspect       Date:  2010-04-19       Impact factor: 9.031

Review 7.  Manganese-induced parkinsonism and Parkinson's disease.

Authors:  C W Olanow
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

Review 8.  Manganism and idiopathic parkinsonism: similarities and differences.

Authors:  D B Calne; N S Chu; C C Huang; C S Lu; W Olanow
Journal:  Neurology       Date:  1994-09       Impact factor: 9.910

9.  Multiple risk factors for Parkinson's disease.

Authors:  Jay M Gorell; Edward L Peterson; Benjamin A Rybicki; Christine Cole Johnson
Journal:  J Neurol Sci       Date:  2004-02-15       Impact factor: 3.181

10.  Manganese inhalation by rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity.

Authors:  Keith M Erikson; David C Dorman; Lawrence H Lash; Michael Aschner
Journal:  Toxicol Sci       Date:  2007-03-07       Impact factor: 4.849

View more
  38 in total

1.  Association of exposure to manganese and iron with striatal and thalamic GABA and other neurometabolites - Neuroimaging results from the WELDOX II study.

Authors:  Swaantje Casjens; Urike Dydak; Shalmali Dharmadhikari; Anne Lotz; Martin Lehnert; Clara Quetscher; Christoph Stewig; Benjamin Glaubitz; Tobias Schmidt-Wilcke; David Edmondson; Chien-Lin Yeh; Tobias Weiss; Christoph van Thriel; Lennard Herrmann; Siegfried Muhlack; Dirk Woitalla; Michael Aschner; Thomas Brüning; Beate Pesch
Journal:  Neurotoxicology       Date:  2017-08-11       Impact factor: 4.294

2.  Modulation of miRNA-155 alters manganese nanoparticle-induced inflammatory response.

Authors:  Matthew W Grogg; Laura K Braydich-Stolle; Elizabeth I Maurer-Gardner; Natasha T Hill; Suraj Sakaram; Madhavi P Kadakia; Saber M Hussain
Journal:  Toxicol Res (Camb)       Date:  2016-10-13       Impact factor: 3.524

3.  Manganese-induced Mitochondrial Dysfunction Is Not Detectable at Exposures Below the Acute Cytotoxic Threshold in Neuronal Cell Types.

Authors:  Emily B Warren; Miles R Bryan; Patricia Morcillo; Keisha N Hardeman; Michael Aschner; Aaron B Bowman
Journal:  Toxicol Sci       Date:  2020-08-01       Impact factor: 4.849

4.  Dysregulation of TFEB contributes to manganese-induced autophagic failure and mitochondrial dysfunction in astrocytes.

Authors:  Ziyan Zhang; Jingqi Yan; Aaron B Bowman; Miles R Bryan; Rajat Singh; Michael Aschner
Journal:  Autophagy       Date:  2019-11-24       Impact factor: 16.016

5.  Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model.

Authors:  Terry Jo V Bichell; Michal Wegrzynowicz; K Grace Tipps; Emma M Bradley; Michael A Uhouse; Miles Bryan; Kyle Horning; Nicole Fisher; Karrie Dudek; Timothy Halbesma; Preethi Umashanker; Andrew D Stubbs; Hunter K Holt; Gunnar F Kwakye; Andrew M Tidball; Roger J Colbran; Michael Aschner; M Diana Neely; Alba Di Pardo; Vittorio Maglione; Alexander Osmand; Aaron B Bowman
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-02-16       Impact factor: 5.187

6.  Putrescine as indicator of manganese neurotoxicity: Dose-response study in human SH-SY5Y cells.

Authors:  Jolyn Fernandes; Joshua D Chandler; Ken H Liu; Karan Uppal; Young-Mi Go; Dean P Jones
Journal:  Food Chem Toxicol       Date:  2018-04-21       Impact factor: 6.023

7.  Mitochondrial ATP-Mg/phosphate carriers transport divalent inorganic cations in complex with ATP.

Authors:  Magnus Monné; Lucia Daddabbo; Lorena Carla Giannossa; Maria Cristina Nicolardi; Luigi Palmieri; Daniela Valeria Miniero; Annarosa Mangone; Ferdinando Palmieri
Journal:  J Bioenerg Biomembr       Date:  2017-07-10       Impact factor: 2.945

8.  A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease.

Authors:  Andrew M Tidball; Miles R Bryan; Michael A Uhouse; Kevin K Kumar; Asad A Aboud; Jack E Feist; Kevin C Ess; M Diana Neely; Michael Aschner; Aaron B Bowman
Journal:  Hum Mol Genet       Date:  2014-12-08       Impact factor: 6.150

9.  ZIP14 is degraded in response to manganese exposure.

Authors:  Khristy J Thompson; Marianne Wessling-Resnick
Journal:  Biometals       Date:  2019-09-20       Impact factor: 2.949

10.  Huntington's disease associated resistance to Mn neurotoxicity is neurodevelopmental stage and neuronal lineage dependent.

Authors:  Piyush Joshi; Caroline Bodnya; Ilyana Ilieva; M Diana Neely; Michael Aschner; Aaron B Bowman
Journal:  Neurotoxicology       Date:  2019-09-20       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.